🤰 GLP-1 medications during pregnancy and breastfeeding: Why it's necessary to press the "pause button" 🚫

In the pursuit of healthy weight and blood sugar management, GLP-1 receptor agonists, such as semaglutide and tesipatide, are undoubtedly revolutionary drugs. However, for women planning pregnancy, already pregnant, or breastfeeding , this convenient path has clear contraindications . This article will explain in detail, based on current medical evidence, why it is necessary to suspend the use of these drugs during this period and provide clear safety guidelines.

🔬 Core Taboo: Why It Must Be Stopped

Currently, all GLP-1 drugs (including GLP-1/GIP dual-target drugs) clearly state in their package inserts that they are contraindicated or should not be used by pregnant women, those planning to become pregnant, or breastfeeding women . This is not unfounded, but primarily based on the following two core reasons:

1. Potential risks to the fetus (contraindications during pregnancy) 👶

a. FDA pregnancy safety classification of C or higher risk📋 : This means that adverse effects on the fetus (such as teratogenicity or growth restriction) have been observed in animal studies, but sufficient, rigorous controlled studies in humans are lacking. Due to ethical considerations, it is impossible to conduct drug trials in pregnant women; therefore, the existence of risk must be assumed until definitive safety evidence is obtained.

b. Specific animal study data 🐁: In animal models, fetuses exposed to GLP-1 drugs have been shown to have an increased risk of skeletal developmental abnormalities, cardiovascular malformations, and neural tube defects . Although the animal doses are much higher than those in humans, this is enough to sound an alarm ⚠️.

c. Mechanism concerns🧠 : GLP-1 drugs work by delaying gastric emptying and regulating appetite and blood sugar. These drastic physiological changes may have unpredictable effects on maintaining a stable and nutritionally balanced intrauterine environment for the fetus .

2. The effects on newborns are unclear (contraindicated during breastfeeding). 👩🍼

a. Will the medication enter breast milk? 🍼 It is currently unclear whether GLP-1 drugs are secreted in large quantities into human breast milk. However, since these drugs are protein drugs (peptides) with relatively small molecular weights, there is a theoretical possibility that they may enter breast milk .

b. Unknown effects on infants ?: Even if trace amounts of the drug enter breast milk, the effects on the newborn's delicate digestive system (potentially affecting feeding), pancreatic development, and long-term metabolism are completely unknown. Any risk that may affect the infant's early development must be avoided.

⏰ Key Action Guidelines: When to Stop Medication and How to Prepare for Pregnancy 🗓️

If you are using GLP-1 medication and planning to welcome a new life, please follow the timeline below and be sure to communicate fully with your doctor (endocrinologist/obstetrician) 👨⚕️👩⚕️:

💡 Alternative Solutions and Integrated Management

Weight and blood sugar management are equally important during pregnancy and breastfeeding, but a shift in mindset is necessary 🔄:

● Gestational blood sugar management : If treatment is needed for diabetes, insulin is the gold standard and safest option for controlling blood sugar during pregnancy 👑 because it does not cross the placenta. Please develop a treatment plan under the joint guidance of an endocrinologist and obstetrician.

● Weight Management and Healthy Living : The focus at this stage should be on balanced nutrition, moderate exercise, and a healthy lifestyle , rather than relying on weight loss medication. Weight management under the guidance of an obstetrician or nutritionist is crucial. 🥗🏃♀️

Please remember that any decisions regarding medication use during pregnancy and breastfeeding must be made in consultation with your obstetrician and endocrinologist. Pregnancy is a special and precious journey🌟, and protecting the health of mother and baby in the safest way is the primary principle. This article is intended to provide information and should not replace professional medical advice.